Literature DB >> 12115601

The impact of c-met/scatter factor receptor on dendritic cell migration.

Steffen M Kurz1, Sandra S Diebold, Thomas Hieronymus, Tatjana C Gust, Petr Bartunek, Martin Sachs, Walter Birchmeier, Martin Zenke.   

Abstract

Dendritic cells (DC) are professional antigen-presenting cells that possess both migratory properties and potent T cell stimulatory activity, and that allow the uptake of antigenic material inperipheral tissues and its subsequent presentation in the T cell areas of lymphoid organs. Thus motility represents a central property that is required for DC function. Here we report on the expression of the receptor tyrosine kinase c-met in DC. c-Met is the high affinity receptor for scatter factor (SF)/hepatocyte growth factor, and ligand-activated c-met exhibits mitogenic, morphogenic andmotogenic activity in vivo and in vitro. c-Met is signaling competent in DC since it is effectively tyrosine phosphorylated in response to SF ligand. It is demonstrated here that ligand-activated c-met regulates DC adhesion to the extracellular matrix component laminin but leaves antigen presenting function unaffected. Importantly, in ear sheet explant experiments activationof c-met by ligand induces emigration of cutaneous DC (Langerhans cell, LC) from skin, but SF is not a chemoattractant factor for DC. Our results suggest an important role of the c-met/SF system in DC/LC migration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115601     DOI: 10.1002/1521-4141(200207)32:7<1832::AID-IMMU1832>3.0.CO;2-2

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells.

Authors:  Mahdia Benkhoucha; Marie-Laure Santiago-Raber; Gregory Schneiter; Michel Chofflon; Hiroshi Funakoshi; Toshikazu Nakamura; Patrice H Lalive
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-23       Impact factor: 11.205

2.  A novel role for Bruton's tyrosine kinase in hepatocyte growth factor-mediated immunoregulation of dendritic cells.

Authors:  Eshu Singhal; Prakash Kumar; Pradip Sen
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

3.  Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death.

Authors:  S Vogel; V Börger; C Peters; M Förster; P Liebfried; K Metzger; R Meisel; W Däubener; T Trapp; J C Fischer; M Gawaz; R V Sorg
Journal:  Cell Death Differ       Date:  2015-01-09       Impact factor: 15.828

4.  Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease.

Authors:  A J Russo; A Krigsman; B Jepson; Andrew Wakefield
Journal:  Biomark Insights       Date:  2009-11-27

5.  Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis.

Authors:  Ferenc Sipos; Miklós Constantinovits; Gábor Valcz; Zsolt Tulassay; Györgyi Műzes
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 6.  Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

Authors:  V Finisguerra; H Prenen; M Mazzone
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

Review 7.  Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment.

Authors:  Ze-Long Liu; Jing-Hua Liu; Daniel Staiculescu; Jiang Chen
Journal:  Ther Adv Med Oncol       Date:  2021-05-24       Impact factor: 8.168

8.  Plasma biomarkers discriminate clinical forms of multiple sclerosis.

Authors:  Marta Tejera-Alhambra; Armanda Casrouge; Clara de Andrés; Ansgar Seyfferth; Rocío Ramos-Medina; Bárbara Alonso; Janet Vega; Lidia Fernández-Paredes; Matthew L Albert; Silvia Sánchez-Ramón
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

Review 9.  Modulation of immunity by antiangiogenic molecules in cancer.

Authors:  Magali Terme; Orianne Colussi; Elie Marcheteau; Corinne Tanchot; Eric Tartour; Julien Taieb
Journal:  Clin Dev Immunol       Date:  2012-12-24

10.  Immunotherapy: shifting the balance of cell-mediated immunity and suppression in human prostate cancer.

Authors:  Jo A Tucker; Caroline Jochems; James L Gulley; Jeffrey Schlom; Kwong Y Tsang
Journal:  Cancers (Basel)       Date:  2012-12-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.